Trial intelligence / Profile preview

Low level laser therapy for prevention of radiotherapy-induced xerostomia

NCT04700475Unknown

Start
Sep 2020
Primary completion
Nov 2020
Countries
1
01

Overview

Randomised, open-label trial in xerostomia. Primary endpoints: Unstimulated salivary flow rate at 7 weeks and Stimulated salivary flow rate at 7 weeks. Status: unknown.

02

Conditions

xerostomia

Beyond the preview

Go deeper on NCT04700475.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04700475.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call